Diabetic Peripheral Neuropathy
📧 Sign up to get email alerts when something new happens for Diabetic Peripheral Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain [Phase 2]
Phase 2 trial results for ETX-018810 in diabetic peripheral neuropathic pain and diabetic peripheral neuropathy have been posted following c…
-
FDA approval · 2023-05-02FDA Approved: DULOXETINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application from Actavis Pharma, Inc. for duloxetine under ANDA 090776, granting approval for a supplemental cha…
-
FDA approval · 2023-03-31FDA Approved: PREGABALIN — Supplemental Application (ScieGen Pharmaceuticals, Inc)
The FDA approved a supplemental application from ScieGen Pharmaceuticals, Inc. for a generic pregabalin product. The approval covers the sam…
-
FDA approval · 2023-03-24FDA Approved: PREGABALIN — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for pregabalin from Solco Healthcare US, LLC under ANDA207883. The drug is indicated for neuropathic…
-
FDA approval · 2023-03-24FDA Approved: PREGABALIN — Supplemental Application (Tris Pharma Inc)
FDA approved a supplemental application for pregabalin submitted by Tris Pharma Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain [NA]
Clinical trial evaluating low level laser therapy for diabetic peripheral neuropathy pain; status terminated with results posted.
-
FDA approval · 2022-09-01FDA Approved: PREGABALIN — Original Application (Solco Healthcare US, LLC)
FDA approved Solco Healthcare US, LLC's original ANDA for pregabalin (generic pregabalin). This marks the approval of a generic version of p…
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating treatment with human umbilical cord mesenchymal stem cells for refractory diabetic peripheral neuropat…
-
FDA approval · 2022-07-26FDA Approved: DULOXETINE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for DULOXETINE submitted by Quallent Pharmaceuticals Health LLC. The notice confirms regulatory …
-
FDA approval · 2022-07-18FDA Approved: PREGABALIN — Original Application (MARKSANS PHARMA LIMITED)
FDA approved the original ANDA for pregabalin from Marksans Pharma Limited (ANDA216197).
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Efficacy of Dapagliflozin in Diabetes Associated Peripheral Neuropathy [Phase 2, Phase 3]
A trial update on the efficacy of dapagliflozin for diabetic peripheral neuropathy across Phase 2 and Phase 3, with unclear status.
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: Effect of the Erchonia® EVRL OTC™ for the Relief of Diabetic Peripheral Neuropathy Foot Pain [NA]
Clinical trial update for Erchonia EVRL OTC intended to relieve diabetic peripheral neuropathy foot pain; the study is completed with result…
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN [Phase 3]
Phase 3 clinical trial of acetyllevocarnitine hydrochloride tablets in Chinese patients with diabetic peripheral neuropathy and paresthesias…
-
FDA approval · 2022-03-22FDA Approved: PREGABALIN — Original Application (Advagen Pharma Ltd.)
FDA approved Pregabalin under an Original Application for Advagen Pharma Ltd., authorizing the generic product.
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Study of Low Level Laser Therapy to Treat Diabetic Peripheral Neuropathy Foot Pain [NA]
A completed clinical trial evaluating low level laser therapy for diabetic peripheral neuropathy foot pain; results posted in 2022.
-
FDA approval · 2022-03-08FDA Approved: PREGABALIN — Original Application (Eskayef Pharmaceuticals Limited)
FDA approved Eskayef Pharmaceuticals Limited's original application for generic pregabalin (ANDA212988).
-
FDA approval · 2022-02-18FDA Approved: PREGABALIN — Original Application (Patrin Pharma, Inc.)
FDA approved an original application for pregabalin from Patrin Pharma, making a generic version available. This marks the approval of a gen…
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 trial evaluating intramuscular injections of human placenta-derived cells (PDA-002) for diabetic peripheral neuropathy has completed…
-
FDA approval · 2022-01-25FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic duloxetine hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2021-07-15FDA Approved: PREGABALIN — Original Application (Tris Pharma Inc)
The FDA approved Tris Pharma's original Abbreviated New Drug Application for pregabalin, allowing a generic pregabalin product to enter the …
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Oral LAT8881 in Neuropathic Pain [Phase 2]
Phase 2 clinical trial update for oral LAT8881 in neuropathic pain conditions has been completed with results posted.
-
FDA approval · 2021-04-13FDA Approved: PREGABALIN — Original Application (Novadoz Pharmaceuticals LLC)
FDA approves the original abbreviated new drug application for pregabalin from Novadoz Pharmaceuticals LLC, enabling a generic version of pr…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome [Phase 2]
Phase 2 clinical trial update for BuqitongluO Granule targeting qi deficiency and blood stasis syndrome in ischemic stroke and related cardi…
-
FDA approval · 2021-03-04FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Tapentadol hydrochloride by Hikma Pharmaceuticals USA Inc., resulting in an updated labeling…
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Topical Menthol +/- Mannitol for Painful Diabetic Peripheral Neuropathy [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating topical menthol with or without mannitol for painful diabetic peripheral neuropathy.